(Q36902041)

17 August 2017

Ocular myasthenia gravis: response to long-term immunosuppressive treatment (English)

1 reference

17 August 2017

0 references

5

Schepelmann K

1 reference

17 August 2017

Sommer N

1

1 reference

17 August 2017

Sigg B

2

1 reference

17 August 2017

Melms A

3

1 reference

17 August 2017

Weller M

4

1 reference

17 August 2017

Herzau V

6

1 reference

17 August 2017

Dichgans J

7

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

17 August 2017

1 reference

17 August 2017

62

1 reference

17 August 2017

2

1 reference

17 August 2017

156-162

1 reference

Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Controversies about the treatment of myasthenia gravis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Thymectomy in myasthenia with pure ocular symptoms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Azathioprine toxicity in neuromuscular disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Long-term corticosteroid treatment of myasthenia gravis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

The course of myasthenia gravis and therapies affecting outcome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

The natural course of myasthenia gravis: a long term follow up study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Remission of myasthenia gravis following plasma-exchange

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

The office Tensilon test for ocular myasthenia gravis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Factors influencing outcome of prednisone dose reduction in myasthenia gravis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

The office Tensilon test for ocular myasthenia gravis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486727

Edrophonium responsiveness not necessarily diagnostic of myasthenia gravis

4 September 2018

1 reference

12 December 2020

[Acetylcholine receptor antibodies in the diagnosis of myasthenia gravis. Study of 406 confirmed cases]

1 reference

12 December 2020

The thymus in seronegative myasthenia gravis patients

1 reference

12 December 2020

A clinical therapeutic trial of cyclosporine in myasthenia gravis

1 reference

12 December 2020

Treatment strategies in myasthenia gravis

1 reference

12 December 2020

Familial autoimmune myasthenia gravis

1 reference

12 December 2020

1 reference

12 December 2020

Associated autoimmune diseases in myasthenia gravis. A population-based study

1 reference

12 December 2020

The treatment of severe myasthenia gravis with immunosuppressive agents

1 reference

12 December 2020

Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens

1 reference

12 December 2020

Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis

1 reference

12 December 2020

Humoral immunity in myasthenia gravis: Biochemical characterization of acquired antireceptor antibodies and clinical correlations

1 reference

12 December 2020

Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients

1 reference

12 December 2020

Prognosis of ocular myasthenia

1 reference

12 December 2020

Accessory nerve stimulation in the assessment of myasthenia gravis

1 reference

12 December 2020

Azathioprine in the treatment of myasthenia gravis

1 reference

12 December 2020

The course of myasthenia gravis in patients treated with corticosteroids, azathioprine, and plasmapheresis

1 reference

12 December 2020

Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis

1 reference

12 December 2020

Seronegative myasthenia gravis

1 reference

12 December 2020

Ocular myasthenia: diagnostic and therapeutic problems

1 reference

12 December 2020

Ocular pseudomyasthenia or ocular myasthenia 'plus': a warning to clinicians

1 reference

12 December 2020

Epidemiological study of myasthenia gravis in the province of Ferrara, Italy

1 reference

12 December 2020

Indications for thymectomy in myasthenia gravis

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.62.2.156

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

9048716

1 reference